Acute myeloid leukemia, t(9;22)(q34.1;q11.2) is a type of blood cancer that affects the bone marrow and blood cells. It is defined by a specific chromosomal change, where parts of chromosomes 9 and 22 swap places. This abnormality is known as the Philadelphia chromosome. The presence of this translocation is a key feature in classifying this form of leukemia. In people with this condition, the abnormal gene rearrangement disrupts normal blood cell development. As a result, the cells may grow and divide abnormally, leading to a swift progression of the disease. Understanding this chromosomal anomaly helps researchers and healthcare professionals better recognize the condition and supports ongoing studies into its underlying biology.

Information about symptoms is currently limited for this condition.

The main cause of acute myeloid leukemia, t(9;22)(q34.1;q11.2) is the presence of a specific chromosomal translocation between chromosomes 9 and 22. This genetic change leads to the formation of the Philadelphia chromosome, which disrupts normal blood cell development. More detailed information about additional risk factors or environmental influences is not available from the provided sources.